SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following news of a multi-year AI compute agreement with OpenAI, including potential stock warrants, leading to significant community discussion about the implications for AMD's market position and future revenue. The collaboration is viewed as a major validation for AMD's technology, with some suggesting it could challenge Nvidia's dominance in the AI chip market. Community members are actively debating the deal's structure and potential impact on AMD's valuation, as well as the broader implications for the AI sector.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin ($APP) is trending due to reports of a SEC probe into its data collection practices, causing a sharp decline in its stock price. The community is debating the severity of the probe, with some viewing it as a buying opportunity and others concerned about potential consequences and overvaluation. Discussions also involve the company's inclusion in the S&P 500 and comparisons to other high-growth tech stocks.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to a significant surge following FDA Breakthrough Therapy Designation for its Sanfilippo syndrome type B treatment, with the community actively discussing the potential for a gamma squeeze and comparing it to other high-flying stocks. Some traders are wary of a potential pullback or secondary offering, while others speculate about further upside and long-term prospects given the small float. The conversation also includes comparisons to other companies and discussions on potential short squeezes.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan is trending as community members discuss its potential as the 'Bitcoin of memecoins' and its strong community. Some users highlight the large number of zeros in its price, while others express excitement about potential gains and compare it to other popular meme coins like $PEPE and $HONK. The community also seems focused on holding for the long term, anticipating a significant increase in market cap.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending as community members discuss its potential as a leader in the burgeoning quantum computing sector, drawing comparisons to early NVIDIA and Tesla. Bullish investors highlight the company's existing revenue, enterprise clients, and government contracts as evidence of traction in a field often dismissed as hype. Concerns about valuation persist, with some arguing that traditional metrics fail to capture the disruptive potential of quantum computing and D-Wave's unique position with tested quantum applications.

Society Pass, Inc. engages in the operation and acquisition of fintech and e-commerce platforms and mobile applications. It operates through the following segments: Online Food and Beverage (F&B) and Groceries Deliveries, Digital Marketing, Online Ticketing and Reservation, e-Commerce, Telecommunication Reseller, and Merchant Point of Sale (POS). The Online F&B and Groceries Deliveries segment includes the operation of Handycart, Mangan, and Pushkart brands. The Digital Marketing segment involves the engagement with creators and management of platforms. The Online Ticketing and Reservation segment focuses on the sale of domestic and overseas air ticket and global hotel reservations. The e-Commerce segment refers to the operation of an online lifestyle platform under the brand name Leflair. The Telecommunication Reseller segment consists of sales of local mobile phone plans and global internet data provider plans. The Merchant POS segment covers the sale of hardware and software. The company was founded by Luan Thuc Nguyen on June 22, 2018 and is headquartered in Carson City, NV.

Society Pass Inc

Society Pass is trending as traders discuss its potential for significant upward movement, drawing comparisons to other high-flying stocks. The community is focused on technical analysis, potential short squeezes, and a recently raised price target from Ascendiant Capital. Some are citing the company's underlying value and upcoming subsidiary IPOs as reasons for optimism.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as gold prices surge, driven by a confluence of factors like a potential government shutdown, a weakening dollar, and anticipation of Federal Reserve rate cuts. Community discussions highlight gold's potential to reach new all-time highs, while some analysts warn of overbought conditions and the possibility of a pullback. The metal's rise is also being attributed to its safe-haven appeal amidst economic uncertainty and geopolitical tensions, with some seeing it as a hedge against a devaluing dollar.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

Applied DNA Sciences is trending due to its planned ticker change to 'BNBX' and a shift towards a digital asset treasury strategy focused on BNB, sparking discussions about potential parallels to other companies that have made similar moves. The community is actively speculating on the potential for a short squeeze and the impact of the new strategy, with some expressing concerns about dilution while others highlight the involvement of figures like Anthony Scaramucci. This is coupled with the company's participation in industry conferences showcasing their DNA platforms.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending amid discussions about its partnerships with AI leaders like Nvidia and OpenAI, with some seeing it as undervalued relative to peers. The community is debating whether the recent price action reflects its potential in the agentic AI space, with some citing CEO stock sales as a concern. Bullish investors are pointing to strong fundamentals and potential for a breakout, while others remain cautious.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CEL-SCI ($CVM) is trending amid news of a Breakthrough Medicine Designation application filed in Saudi Arabia for its cancer immunotherapy, Multikine, generating excitement for potential near-term revenue. The community is actively discussing the implications of this filing with potential partnerships and market entry, weighing the opportunity against the backdrop of the company's history and financial status. Some are skeptical, citing past failures and dilution concerns, while others remain bullish, anticipating a significant catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership

TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which aims to evaluate the clinical utility of its...

Is the Options Market Predicting a Spike in Veracyte Stock?

Investors need to pay close attention to VCYT stock based on the movements in the options market lately.

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Veracyte (VCYT) is a Strong Growth Stock

VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up

Veracyte Q2 earnings and revenues beat estimates, fueled by Decipher and Afirma growth, sending shares up over 15%. 

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of +41.94% and +7.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Veracyte Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

VCYT
Veracyte Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VCYT News

VCYT Veracyte Inc